146 related articles for article (PubMed ID: 35571788)
21. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.
Wei Z; Shan Z; Shaikh ZA
Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589
[TBL] [Abstract][Full Text] [Related]
22. A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.
Soh RYZ; Lim JP; Samy RP; Chua PJ; Bay BH
Exp Mol Pathol; 2018 Dec; 105(3):364-370. PubMed ID: 30385176
[TBL] [Abstract][Full Text] [Related]
23. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
24. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles from MDA-MB-231 breast cancer cells stimulated with linoleic acid promote an EMT-like process in MCF10A cells.
Galindo-Hernandez O; Serna-Marquez N; Castillo-Sanchez R; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):299-310. PubMed ID: 25301203
[TBL] [Abstract][Full Text] [Related]
26. SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice.
Sun Q; Peng Y; Zhao Q; Yan S; Liu S; Yang Q; Liu K; Rokosh DG; Jiao K
Dev Biol; 2019 Aug; 452(1):1-7. PubMed ID: 31042497
[TBL] [Abstract][Full Text] [Related]
27. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.
Gao G; Liang X; Ma W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3839-3846. PubMed ID: 31556312
[TBL] [Abstract][Full Text] [Related]
28. Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation.
Liu Z; Huang L; Sun L; Nie H; Liang Y; Huang J; Wu F; Hu X
Drug Des Devel Ther; 2021; 15():3451-3461. PubMed ID: 34408399
[TBL] [Abstract][Full Text] [Related]
29. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.
Park S; Han SH; Kim HG; Jeong J; Choi M; Kim HY; Kim MG; Park JK; Han JE; Cho GJ; Kim MO; Ryoo ZY; Choi SK
Mol Cell Probes; 2019 Oct; 47():101440. PubMed ID: 31445970
[TBL] [Abstract][Full Text] [Related]
30. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
31. BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.
Litzenburger BC; Kim HJ; Kuiatse I; Carboni JM; Attar RM; Gottardis MM; Fairchild CR; Lee AV
Clin Cancer Res; 2009 Jan; 15(1):226-37. PubMed ID: 19118050
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
34. Adenylyl Cyclase Type 8 Overexpression Impairs Phosphorylation-Dependent Orai1 Inactivation and Promotes Migration in MDA-MB-231 Breast Cancer Cells.
Sanchez-Collado J; Lopez JJ; Jardin I; Camello PJ; Falcon D; Regodon S; Salido GM; Smani T; Rosado JA
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652779
[TBL] [Abstract][Full Text] [Related]
35. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
[TBL] [Abstract][Full Text] [Related]
36. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
37. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of odd-skipped related transcription factor 1 promotes proliferation and invasion of breast cancer cells and indicates poor patient prognosis.
Wang Y; Lei L; Xu F; Xu HT
Oncol Lett; 2020 Sep; 20(3):2946-2954. PubMed ID: 32782611
[TBL] [Abstract][Full Text] [Related]
39. microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.
Han M; Wang Y; Guo G; Li L; Dou D; Ge X; Lv P; Wang F; Gu Y
J Cell Biochem; 2018 Nov; 119(10):8138-8145. PubMed ID: 29923255
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]